Study 02: what did people gain or lose?
Tesamorelin Research: What Did Each Study Show?
The studies found changes in deep belly fat, liver fat, and side effects. Each result is tied to the people tested.
What can the tesamorelin studies tell you?
Tesamorelin studies show what changed in people with HIV and excess deep belly fat. The sections explain growth hormone, fat changes, and side effects in an order you can follow.
The medicine leaves the blood in less than an hour. Yet the hormone change lasts all day, which helps explain the daily study plan.
A bracketed number leads to the source for each claim. Group results aren't a personal target or a promise for you.
How does tesamorelin raise 1 key growth protein?
Step 1 starts when tesamorelin attaches to the growth gland below the brain, prompting more growth hormone [1]. In 1 later step, that hormone tells the liver to make 1 protein that helps the body draw on stored fat [1][1].
The change was strongest in deep belly fat during the studies. Tesamorelin prompts timed hormone release instead of giving a steady outside dose.
The body's usual checks therefore remain at work [4]. This is 1 key difference from a shot of growth hormone itself.
In a rat study, a second drug blocked the same body step and stopped the heart effect [10]. The drug's lab name ended in 602, but that number wasn't a dose.
That heart result came from rats, not people. It can't show whether tesamorelin helps a person's heart.
What did the main belly-fat studies find?
The 26-week study was large late-stage work, called Phase 3, with 412 people who had HIV [1]. People received 2 milligrams a day or a sugar pill; one blood fat fell 50 milligrams per deciliter with tesamorelin and rose 9 milligrams per deciliter with sugar pills.
The 52-week follow-up had 273 people on tesamorelin and 137 on sugar pills. The drug group still had 18% less deep belly fat [2].
In 2026, reviewers combined five fair tests [12]. Their 95% check allowed for chance, and the whole likely span still showed less deep fat.
The review also found less trunk fat and more weight from lean tissue. Just 1 liver-made growth protein rose, yet no serious side effects were reported.
A later check found similar results with or without an upper-back fat pad [6]. The comparison did not show that the pad changed the medicine's effect.
Tesamorelin reduced deep belly fat more than fat under the skin. The belly-fat page explains how long the change lasted and what remains unknown.
What did each tesamorelin liver-fat study find?
Tesamorelin has been tested for liver fat in people with HIV, but it isn't approved to treat fatty liver. A 6-month study followed 50 adults; those given 2 milligrams a day had 42 square centimeters less deep fat on a scan [3].
That square measure came from a flat scan image, not fat removed from the body. The same study also found less fat in the liver.
In 2024, another 12-month study followed people with HIV. The scan measure fell 25 square centimeters with tesamorelin and rose 14 square centimeters with a sugar pill [13].
The drug group also had less liver fat. The study found enough of a gap that chance was an unlikely cause.
In 2026, a review combined several tests and again found less liver fat [12]. Tesamorelin still isn't an approved liver treatment for you.
A separate 12-month study linked deep fat with worse liver scars. For each extra 25 square centimeters on the scan, the odds of worse scars rose 37% [9].
Is tesamorelin approved for fatty liver?
Tesamorelin is still being studied for fatty liver in people with HIV. It isn't approved for that disease.
In 2014, a study found less liver fat with tesamorelin [3]. In 2026, a review of fair tests reached the same broad finding [12].
Review authors saw promise for fatty liver tied to HIV. They still didn't know whether tesamorelin could slow or prevent scars in liver tissue [11].
What changed inside the liver after tesamorelin?
Tesamorelin may help the liver by lowering liver fat and deep belly fat. More deep fat is tied to a higher risk of liver scars.
After 12 months, liver tissue from people with HIV showed two changes. Its cells made energy better, while signs of swelling and scar-making fell [3].
The study did not show whether those cell changes would slow liver scars. Tesamorelin has not been proved to prevent such scars [9][11].
Who was in the tesamorelin liver-fat studies?
The studies found less liver fat in the groups tested. All of those people had HIV and fatty liver.
In 2014, one study found a drop after tesamorelin [3]. A later review agreed, but the drug still isn't an approved liver treatment [12].
How long does tesamorelin stay in the blood?
Tesamorelin leaves blood quickly, and one lab calculation gave a clearing rate of 1,060 liters per hour [1]. That figure means the drug level fell fast; it doesn't mean blood or fluid left your body.
One study found 13% more of the dose reached blood by day 14 than day 1. Age and similar traits did not change the result enough to matter.
Medical sources say the level falls well before 1 hour. The time for half to leave is called its half-life.
The drug leaves fast, but its hormone effect lasts through the day [1]. That longer effect supported the daily plan used in the studies.
A small added part slows how fast the body breaks tesamorelin down [1][7]. That helps the medicine last longer than the natural brain message it copies.
Does tesamorelin raise 1 growth protein in the blood?
Yes, tesamorelin raises 1 growth protein made by the liver. Growth hormone tells the liver to make more of that protein.
The main study found that 1 protein rose clearly [1]. In healthy men, the rise was 181 micrograms per liter [4].
That 1 protein helps cells grow, so the increase can matter for safety. The label names 1 group that must not use tesamorelin: people with active cancer [5].
What makes growth hormone rise after tesamorelin?
Tesamorelin attaches to cells in the growth gland. The contact tells those cells to make and release growth hormone [1].
The hormone then rises in its usual bursts. In healthy men, a two-week test used 2 milligrams a day and found a rise overnight [4].
The gap was strong enough that chance was an unlikely cause. This small study explains a body step, not a sure benefit for you.
Which side effects and reasons to avoid it were reported?
Studies most often found shot-site soreness, joint pain, held fluid, headache, and tingling [7]. One review found serious side effects in fewer than 4% over 26 weeks, while another found more joint pain and swelling than with sugar pills [7][8].
Federal rules warn that tesamorelin raises 1 liver-made growth protein. The drug is barred during pregnancy, with active cancer, or after a bad reaction [5].
A federal drug-safety review found no clear cases of liver harm. The trials also found no new rise in blood tests that can warn of liver injury [5].
The FAQ covers blood sugar, and the dose page lists study amounts. Those pages can help you prepare questions for your doctor.